Medacta Usa Inc recalls Medacta Shoulder SYSTEM HUMERAL ANATOMICAL METAPHYSIS, REF 04.01.0023 through 04.01.0055, all sizes - Product Usage: Th…
- Recall date
- November 4, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0775-2020
- FDA classification
- Class II
- Brand / firm
- Medacta Usa Inc
- Sold / distributed
- US Nationwide distribution in the states of KY, NJ, IL, SC, CA, TX, ID, AR, OH.
Why it was recalled
Certain lot numbers of the Medacta Humeral Anatomical Cementless Metaphysis have a dimensional condition that could limit insertion of the screw used to lock the metaphysis to the humeral diaphysis.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Medacta Shoulder SYSTEM HUMERAL ANATOMICAL METAPHYSIS, REF 04.01.0023 through 04.01.0055, all sizes - Product Usage: The Medacta Anatomic Shoulder Prosthesis is indicated for treatment of humeral fractures and for primary or revision total shoulder replacement in patients with an intact or reparable rotator cuff shoulder joint, severe arthropathy or a previously failed joint replacement.
Get recall alerts
Free email alert whenever Medacta Usa Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medacta Usa Inc